Osthole Prevents 6-Hydroxydopamine (6-OHDA) Induced Endoplasmic Reticulum Stress and Cytotoxicity Through Activating Akt/GSK3beta Signaling Pathway in PC12 Cells

Hua Mei,Ming Shen,Saisai Xie,Shilin Yang,Heru Chen,Yi Jin,Rikang Wang
2017-01-01
Latin american journal of pharmacy
Abstract:Osthole, a coumarin compound extracted from Cnidium monnieri, was found potently attenuated 6-hydroxydopamine (6-OHDA)-induced cytotoxicity and apoptosis. It significantly decreased intracellular reactive oxygen species (ROS) and prevented the decline of mitochondrial membrane potential and intracellular GSH level induced by 6-OHDA. As reported, 6-OHDA evoked endoplasmic reticulum (ER) stress, which plays a major role in several neurodegenerative diseases, including Parkinson's disease (PD). Quite interestingly, osthole markedly reduced 6-OHDA induced ER stress, including the upregulated levels of glucose-regulated protein-78 (GRP78), and MEP homologous protein (CHOP) expression. Moreover, treatment with osthole restored the p-Akt and p-GSK-3 beta (Ser9) reduced by 6-OHDA. Furthermore, the protective effect of osthole on ER stress was attenuated by LY294002, a selective PI3K inhibitor. The shRNA knockdown results showed that down regulated Akt1 or GSK-3 beta attenuated the protective effect of osthole, indicating that the Akt/GSK-3 beta pathway was involved in the neuroprotective effect of osthole. Taken together, our findings suggest that the protective effect of osthole against 6-OHDA-induced ER stress and oxidative stress injuries in PC12 cells involves the Akt/GSK-3 beta pathway.
What problem does this paper attempt to address?